ARQ-197 enhances the antitumor effect of sorafenib in hepatocellular carcinoma cells via decelerating its intracellular clearance
Xudong Gao,1,2 Hebing Chen,1 Xin Huang,1 Hao Li,1 Zhen Liu,1 Xiaochen Bo1 1Beijing Institute of Radiation Medicine, Beijing 100850, People’s Republic of China; 2The 5th Medical Center of PLA General Hospital, Beijing 100039, People’s Republic of China Background: Hepatocellular...
Main Authors: | Gao X, Chen H, Huang X, Li H, Liu Z, Bo X |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-02-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/arq-197-enhances-the-antitumor-effect-of-sorafenib-in-hepatocellular-c-peer-reviewed-article-OTT |
Similar Items
-
Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cells
by: Wu M, et al.
Published: (2018-05-01) -
Profile of tivantinib and its potential in the treatment of hepatocellular carcinoma: the evidence to date
by: Pievsky D, et al.
Published: (2016-11-01) -
Multiple Roles of Autophagy in the Sorafenib Resistance of Hepatocellular Carcinoma
by: Ting Sun, et al.
Published: (2017-11-01) -
Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity
by: Loraine Kay D. Cabral, et al.
Published: (2020-06-01) -
MicroRNA-375 Targets ATG14 to Inhibit Autophagy and Sensitize Hepatocellular Carcinoma Cells to Sorafenib
by: Yang S, et al.
Published: (2020-04-01)